T. Rowe Price Associates, Inc. 13D and 13G filings for QuidelOrtho Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | QuidelOrtho Corporation QDEL | T. Rowe Price Associates, Inc. | 6,108,899 14.600% | -316,424 (-4.92%) | Filing |
| 2021-04-12 2:07 pm Purchase | 2021-03-31 | 13G | QuidelOrtho Corporation QDEL | T. Rowe Price Associates, Inc. | 6,425,323 15.100% | 2,163,485 (+50.76%) | Filing |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | QuidelOrtho Corporation QDEL | T. Rowe Price Associates, Inc. | 4,261,838 10.100% | 25,123 (+0.59%) | Filing |
| 2020-10-13 11:26 am Purchase | 2020-09-30 | 13G | QuidelOrtho Corporation QDEL | T. Rowe Price Associates, Inc. | 4,236,715 10.000% | 917,830 (+27.65%) | Filing |
| 2020-08-10 1:47 pm Sale | 2020-07-31 | 13G | QuidelOrtho Corporation QDEL | T. Rowe Price Associates, Inc. | 3,318,885 7.900% | -2,398,860 (-41.95%) | Filing |